Employees: 01 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 1991-10-17 (34 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NICE (06000), Alpes-Maritimes
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE LAMARTINE REBOUL : revenue, balance sheet and financial ratios
PHARMACIE LAMARTINE REBOUL is a French company
founded 34 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NICE (06000),
this company of category PME
shows in 2016 a revenue of 523 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LAMARTINE REBOUL (SIREN 383309606)
Indicator
2020
2016
Revenue
N/C
522 889 €
Net income
78 351 €
50 534 €
EBITDA
N/C
64 768 €
Net margin
N/C
9.7%
Revenue and income statement
In 2020, PHARMACIE LAMARTINE REBOUL generates positive net income of 78 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 51 k€ -> 78 k€.
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
78 351 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 319%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 21%. The balance between equity and debt is satisfactory.
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
319.149%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
20.775%
Asset age ratio (2020)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2020
Debt ratio
424.407
319.149
Financial autonomy
16.004
20.775
Repayment capacity
4.428
None
Cash flow / Revenue
12.333%
None%
Sector positioning
Debt ratio
319.152020
2016
2020
Q1: 33.2
Med: 96.78
Q3: 238.43
Average
In 2020, the debt ratio of PHARMACIE LAMARTINE REBOUL (319.15) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
20.77%2020
2016
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.95%
Watch
In 2020, the financial autonomy of PHARMACIE LAMARTINE REBOUL (20.8%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
4.43 years2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Good
In 2016, the repayment capacity of PHARMACIE LAMARTINE REBOUL (4.43) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 187.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2020)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2020
Liquidity ratio
150.395
187.844
Interest coverage
0.423
None
Sector positioning
Liquidity ratio
187.842020
2016
2020
Q1: 133.12
Med: 181.89
Q3: 251.9
Good+6 pts over 2 years
In 2020, the liquidity ratio of PHARMACIE LAMARTINE REBOUL (187.84) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.42x2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.31x
Average
In 2016, the interest coverage of PHARMACIE LAMARTINE REBOUL (0.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 114 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 394 days. Excellent situation: suppliers finance 280 days of the operating cycle (retail model).
Operating WCR (2020)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2020)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
114 j
Supplier credit (2020)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
394 j
Inventory turnover (2020)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE LAMARTINE REBOUL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2020
Operating WCR
41 664 €
0 €
Inventory turnover (days)
24
0
Customer payment term (days)
11
114
Supplier payment term (days)
33
394
Positioning of PHARMACIE LAMARTINE REBOUL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 180 transactions of similar company sales
in 2020,
the value of PHARMACIE LAMARTINE REBOUL is estimated at
1 107 307 €
(range 738 337€ - 1 494 057€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2020
180 transactions
738k€1107k€1494k€
1 107 307 €Range: 738 337€ - 1 494 057€
NAF 5 année 2020
Valuation method used
Net Income Multiple
78 351 €
×
14.1x
=1 107 308 €
Range: 738 337€ - 1 494 057€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LAMARTINE REBOUL with other companies in the same sector:
Frequently asked questions about PHARMACIE LAMARTINE REBOUL
What is the revenue of PHARMACIE LAMARTINE REBOUL ?
The revenue of PHARMACIE LAMARTINE REBOUL in 2016 is 523 k€.
Is PHARMACIE LAMARTINE REBOUL profitable?
Yes, PHARMACIE LAMARTINE REBOUL generated a net profit of 78 k€ in 2020.
Where is the headquarters of PHARMACIE LAMARTINE REBOUL ?
The headquarters of PHARMACIE LAMARTINE REBOUL is located in NICE (06000), in the department Alpes-Maritimes.
Where to find the tax return of PHARMACIE LAMARTINE REBOUL ?
The tax return of PHARMACIE LAMARTINE REBOUL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LAMARTINE REBOUL operate?
PHARMACIE LAMARTINE REBOUL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart